Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Elina Fredlund"'
Autor:
Elina Fredlund, Stina Andersson, Elien Hilgert, Guadalupe Álvarez-Hernán, Ezequiel Monferrer, Sinan Karakaya, Tomas Gregor, Siebe Loontiens, Jan Willem Bek, Estelle Lecomte, Emma Magnusson, Enrika Miltenyte, Marie Cabirol, Michail Kyknas, Niklas Engström, Marie Arsenian Henriksson, Emma Hammarlund, Rosa Noguera, Frank Speleman, Johan van Nes, Sofie Mohlin
Neuroblastoma is a childhood cancer believed to result from dysfunctional development. Its origin during embryogenesis remains poorly understood. The lack of appropriate models has hindered in-depth mapping of tumor-driving events. Here, we identify
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d30d650819002dbe172d6ed75f44c405
https://doi.org/10.1101/2023.01.17.524367
https://doi.org/10.1101/2023.01.17.524367
Autor:
Elina Fredlund, Stina Andersson, Elien Hilgert, Guadalupe Alvares Hernan, Ezequiel Monferrer, Sinan Karakaya, Tomas Gregor, Siebe Loontiens, Jan Willem Bek, Estelle Lecomte, Emma Magnusson, Enrika Miltenyte, Marie Cabirol, Michail Kyknas, Niklas Engström, Marie Arsenain-Henriksson, Emma Hammarlund, Rosa Noguera, Frank Speleman, Johan van Nes, Sofie Mohlin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ebbce025a7678d428c5db79a41b48d56
https://doi.org/10.2139/ssrn.4367309
https://doi.org/10.2139/ssrn.4367309
Autor:
Subhayan Chattopadhyay, Jenny Karlsson, Adriana Mañas, Ryu Kanzaki, Elina Fredlund, Andrew J. Murphy, Christopher L. Morton, Natalie Andersson, Mary A. Woolard, Karin Hansson, Katarzyna Radke, Andrew M. Davidhoff, Sofie Mohlin, Kristian Pietras, Daniel Bexell, David Gisselsson
Despite the advent of personalized medicine, it is still difficult to predict how a cancer develops over time at the level of the individual patient or even in cancer model systems which begs the question whether certain aspects of cancer can ever be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::13cd894430076d08044494416feb75c5
https://doi.org/10.1101/2022.06.01.494285
https://doi.org/10.1101/2022.06.01.494285
Autor:
Elina Fredlund, Emil Önell, Felicia Fält, Stina Oredsson, Plaurent Roci, Atena Malakpour Permlid, Fredrik Johansson
Publikováno v:
Toxicology in Vitro. 60:51-60
Two-dimensional cell culturing has proven inadequate as a reliable preclinical tumour model due to many inherent limitations. Hence, novel three-dimensional (3D) cell culture models are needed, which in many aspects can mimic a native tumour with 3D
Autor:
Camilla U. Niklasson, Marianne E. Bronner, Emma U. Hammarlund, Sofie Mohlin, Zaal Kokaia, Elina Fredlund, Emanuela Monni, Jessica M. Lindvall
Publikováno v:
Developmental Dynamics
Background The neural crest is a transient embryonic stem cell population. Hypoxia inducible factor (HIF)‐2α is associated with neural crest stem cell appearance and aggressiveness in tumors. However, little is known about its role in normal neura
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::538f97e6ed7c4b87ec6a6b647cc12ef9
https://resolver.caltech.edu/CaltechAUTHORS:20200923-074659440
https://resolver.caltech.edu/CaltechAUTHORS:20200923-074659440
Autor:
Emma U. Hammarlund, Jessica M. Lindvall, Zaal Kokaia, Emanuela Monni, Marianne E. Bronner, Camilla Persson, Elina Fredlund, Sofie Mohlin
The neural crest is a stem cell population that gives rise to sympathetic ganglia, the cell type of origin of neuroblastoma. Hypoxia Inducible Factor (HIF)-2α is associated with high risk neuroblastoma, however, little is known about its role in nor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6284eb72be5c7259ae6e5037fa978cc8
https://doi.org/10.1101/2020.01.22.915199
https://doi.org/10.1101/2020.01.22.915199
Autor:
Camilla U, Persson, Kristoffer, von Stedingk, Elina, Fredlund, Daniel, Bexell, Sven, Påhlman, Caroline, Wigerup, Sofie, Mohlin
Publikováno v:
Experimental cell research. 388(2)
Hypoxia-inducible factor (HIF)-2α associates with poor outcome in neuroblastoma and glioblastoma, and gain-of-function mutations in the EPAS1 gene (encoding HIF-2α) have been reported in paragangliomas and pheochromocytomas. Specific targeting of a